| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids. | EMBO Mol Med | 2014 | 0.83 |
| 2 | Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin. | J Cancer Prev | 2015 | 0.76 |
| 3 | Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids. | Oncotarget | 2016 | 0.75 |
| 4 | The long winding road to the safer glucocorticoid receptor (GR) targeting therapies. | Oncotarget | 2022 | 0.75 |